Product Information
CAMRESE LO TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2339 per EA under NDC 00093614882. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Oct 24, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093614882
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Authorized Generic (NDA)
FDA Application
NDA022262FDA Approved
10/24/2008
TE Code
AB
On Market Since
12/7/2011
Price Statistics
The NADAC for CAMRESE LO TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 86.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2339 per EA |
|---|---|
| All-time high | $1.9783 (Feb 12, 2014) |
| All-time low | $0.1337 (Jul 17, 2024) |
| 52-week high | $0.2436 |
| 52-week low | $0.1911 |
| Median price | $0.4012 |
| Average price | $0.8633 |
| Largest weekly change | +86.4% (Nov 22, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CAMRESE LO TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CAMRESE LO TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2339 per EA (NDC 00093614882), effective Sep 30, 2026.
How has the price of CAMRESE LO TABLET changed over time?
Over the history we have for it, the NADAC for CAMRESE LO TABLET has declined 86.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CAMRESE LO TABLET?
Since Nov 28, 2013, the NADAC for CAMRESE LO TABLET has ranged from a low of $0.1337 (Jul 17, 2024) to a high of $1.9783 (Feb 12, 2014), with a median of $0.4012 per EA.
Are there cheaper alternatives to CAMRESE LO TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CAMRESE LO TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CAMRESE LO TABLET?
CAMRESE LO TABLET (NDC 00093614882) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.